Hamps Bio Limited (BOM:544312)

Market Cap	197.11M
Revenue (ttm)	64.75M
Net Income (ttm)	5.01M
Shares Out	4.36M
EPS (ttm)	1.70
PE Ratio	26.69
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,000
Average Volume	4,700
Open	42.75
Previous Close	n/a
Day's Range	42.75 - 42.75
52-Week Range	40.35 - 107.20
Beta	n/a
RSI	48.52
Earnings Date	n/a

About Hamps Bio

Hamps Bio Limited provides pharmaceutical formulation, and freeze dried and frozen products in India and internationally. The company offers pharmaceutical products that are used as nutrition supplement, injections, pediatric care, toothpaste, mouth wash, antiacid/PPI, painkiller/anti-inflammatory, hematantic/calcium supplement, and anti-biotic/anti-bacterial/anti-fungal. It also offers dry freeze food products comprising of ready to eat foods, juices, ice cream powder, smoothie, tea, fruit snacks, milk related, and other dry food products. Ham...

• Industry: Pharmaceutical Preparations
• Founded: 2007
• Employees: 73
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544312

Financial Performance

In 2023, Hamps Bio's revenue was 64.75 million, an increase of 16.08% compared to the previous year's 55.78 million. Earnings were 5.01 million, an increase of 39.47%.